ENTA
Enanta Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $235.37M | Price | $10.96 |
| Volume | 367.96K | Change | +0.92% |
| P/E Ratio | -2.0 | Open | $10.89 |
| Revenue | $67.6M | Prev Close | $10.86 |
| Net Income | $-116.0M | 52W Range | $4.09 - $15.34 |
| Div Yield | N/A | Target | $17.67 |
| Overall | 49 | Value | 60 |
| Quality | 23 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyEnanta Pharmaceuticals Inc. (ENTA) is a leading Healthcare company in the Biotechnology industry, currently trading at $10.96 with a market capitalization of $235.37 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows ENTA with a volume of 368K shares. The stock opened up 0.28% from yesterday's close of $10.86. Current analyst estimates project earnings of $-4.1 per share for this year, with next year targeting $-2.75.
ENTA demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ENZN, ABBV, JNJ, VRTX, MRK.
Key investment considerations for ENTA include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 61.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 01:57 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENTA | $10.96 | +0.9% | 367.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enanta Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW